Trial evaluates maternal vaccine to protect newborns from Group B Streptococcus

Researchers from the Wits Vaccines and Infectious Diseases Analytics (Wits VIDA) Research Unit astatine the University of the Witwatersrand (Wits) person played a starring relation successful an planetary signifier 1/2 objective proceedings demonstrating the information and immunogenicity of an investigational maternal vaccine against Group B Streptococcus (GBS)—a large origin of life-threatening infections successful newborns worldwide. The findings person been published successful Nature Medicine.